51 infectious disease mRNA vaccines are currently in development.

Moderna (14)
- mRNA-1018 — pandemic flu — Phase 3
- mRNA-1403 — norovirus — Phase 3
- mRNA-1405 — norovirus — Phase 2
- mRNA-1345 — pediatric RSV — Phase 2
- mRNA-1647 — CMV — Phase 2
- mRNA-1189 — EBV (mono) — Phase 2
- mRNA-1195 — EBV (long-term sequelae) — Phase 2
- mRNA-1975 — Lyme — Phase 2
- mRNA-1982 — Lyme — Phase 2
- mRNA-1769 — mpox — Phase 2
- mRNA-1365 — RSV + hMPV — Phase 1
- mRNA-1645 — HIV — Phase 1
- mRNA-1215 — Nipah — Phase 1
- mRNA-1469 — Bundibugyo ebolavirus — Phase 1

BioNTech / Pfizer (7)
- BNT162 + BNT161 — COVID + flu combo
- BNT163 — HSV
- BNT164 — tuberculosis
- BNT165 — malaria
- BNT166 — mpox
- BNT351 — HIV
- Pfizer modRNA flu (PF-07252220), Phase 3

GSK (4)
- GSK4382276 / FLUm3HA.b-3NA, Phase 3
- GSK4396687 — 2nd-generation COVID19, Phase 1/2
- GSK5536522 — pandemic H5N1 flu, Phase 1/2
- Flu + COVID combination, Phase 1/2

Arcturus (saRNA) (2)
- ARCT-2138 (LUNAR-FLU) - seasonal flu, Phase 1
- ARCT-2304 (LUNAR-H5N1)- pandemic H5N1, Phase 1

Sanofi (1)
- mRNA acne vaccine (C. acnes) - Phase 1/2

CSPC (5)
- SYS6006 — COVID-19, Phase 2
- SYS-6017 — herpes zoster, China trial clearance
- SYS-6052 — herpes zoster, FDA IND
- SYS-6037 — mpox, FDA IND
- SYS-6057 — RSV, China trial clearance (mRNA not confirmed)

Walvax / Abogen (4)
- RSV mRNA vaccine — clinical-trial approval
- Herpes zoster mRNA vaccine — clinical-trial approval
- ABO1009-DP — Omicron COVID, Phase 1
- ARCoV — COVID, Phase 3

Other, including self-amplifying (14)
- CanSino CTP-NCVM — COVID — Phase 2
- AIM LVRNA009 — COVID — Phase 3
- Daiichi Sankyo DS-5670 — COVID — Phase 1/2
- Stemirna SWC002 — COVID — Phase 1/2
- EyeGene EG-COVID — COVID — Phase 1/2
- HDT Bio HDT-301 — saRNA COVID — Phase 1–2
- RVAC RVM-V001 — COVID — Phase 1
- RNAimmune RV-1770 — RSV — Phase 1
- RNAimmune RV-1730 — COVID booster — Phase 1
- AstraZeneca AZD6563 — mRNA VLP COVID, Phase 1
- Providence PTX-COVID19-B — COVID — Phase 1–2
- VLPCOV-1 to VLPCOV-5 / VLPCOV-U-1 — VLP Therapeutics — saRNA COVID — Phase 3
- Seqirus saRNA flu (HA + NA) — seasonal flu — Phase 1
- RBI-4000 — Replicate Bioscience — saRNA rabies — Phase 1

https://x.com/MaryBowdenMD/status/2107974503888294115